Serum Levels of Selected Th17 and Th22 Cytokines in Psoriatic Patients. Issue 6 (31st October 2013)

• Record Type: Journal Article
• Authors: Michalak-Stoma, Anna; Bartosińska, Joanna; Kowal, Małgorzata; Juszkiewicz-Borowiec, Maria; Gerkowicz, Agnieszka; Chodorowska, Grażyna
• Other Names: Ortega Esperanza Academic Editor.
• Is Part Of: Disease markers. Volume 35:Issue 6(2013)
• Page Start: 625
• Page End: 631
• Publication Date: 2013-10-31
• Subjects: Diagnosis -- Periodicals; Biochemical markers -- Periodicals; Pathology -- Periodicals; 616
• DOI: 10.1155/2013/856056
• Languages: English
• ISSNs: 0278-0240

Abstract

Abstract : Introduction . Psoriasis is a T cell-mediated inflammatory disease in which pathogenesis T helper (Th) lymphocytes (Th1, Th17, and Th22) play an important role. The aim of the study was to assess the serum levels of some cytokines involved in the Th17 and Th22 responses in psoriatic patients. Material and Methods . The study comprised 60 psoriatic patients and 30 healthy controls. In the serum collected from psoriatic patients and healthy controls, the concentrations of IL-6, IL-12, IL-17, IL-20, IL-22, and IL-23 were examined with ELISA kits. Severity of psoriatic skin lesions was assessed by means of PASI, BSA, and PGA scores. Results . IL-6, IL-20, and IL-22 concentrations were significantly higher in psoriatic patients in comparison with the control group. The positive correlations between the concentrations of IL-22 and IL-20 and severity of psoriasis assessed with PASI and BSA scores as well as IL-17 and PASI score were found. There was also a positive correlation between IL-23 and IL-17 concentrations. Conclusions . Results of the conducted studies suggest that Th22 response may contribute to the skin and systemic inflammatory disease in psoriasis. It seems that early identification of soluble biomarkers and initiation of well-matched treatment may prevent exacerbation and progression of psoriasis.